Humacyte, Inc. (HUMA)
HUMA Stock Price Chart
Explore Humacyte, Inc. interactive price chart. Choose custom timeframes to analyze HUMA price movements and trends.
HUMA Company Profile
Discover essential business fundamentals and corporate details for Humacyte, Inc. (HUMA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Dec 2020
Employees
218.00
Website
https://www.humacyte.comCEO
Laura E. Niklason
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
HUMA Financial Timeline
Browse a chronological timeline of Humacyte, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 14 Nov 2025
EPS estimate is -$0.17.
Earnings released on 11 Aug 2025
EPS came in at -$0.24 falling short of the estimated -$0.15 by -60.00%, while revenue for the quarter reached $301.00K , missing expectations by -67.21%.
Earnings released on 13 May 2025
EPS came in at -$0.10 surpassing the estimated -$0.19 by +47.37%, while revenue for the quarter reached $517.00K , missing expectations by -32.40%.
Earnings released on 28 Mar 2025
EPS came in at -$0.16 surpassing the estimated -$0.23 by +30.43%, while revenue for the quarter reached $7.23M , beating expectations by +1.03K%.
Earnings released on 8 Nov 2024
EPS came in at -$0.33 falling short of the estimated -$0.26 by -26.92%.
Earnings released on 13 Aug 2024
EPS came in at -$0.27 falling short of the estimated -$0.23 by -17.39%.
Earnings released on 10 May 2024
EPS came in at -$0.29 falling short of the estimated -$0.23 by -26.09%.
Earnings released on 22 Mar 2024
EPS came in at -$0.24 surpassing the estimated -$0.25 by +4.00%, while revenue for the quarter reached $10.79M , beating expectations by +17.88K%.
Earnings released on 9 Nov 2023
EPS came in at -$0.25 matching the estimated -$0.25.
Earnings released on 14 Aug 2023
EPS came in at -$0.22 matching the estimated -$0.22.
Earnings released on 12 May 2023
EPS came in at -$0.22 matching the estimated -$0.22.
Earnings released on 24 Mar 2023
EPS came in at -$0.21 surpassing the estimated -$0.24 by +12.50%, while revenue for the quarter reached $5.00K , missing expectations by -97.50%.
Earnings released on 10 Nov 2022
EPS came in at -$0.25 falling short of the estimated -$0.21 by -19.05%, while revenue for the quarter reached $31.00K , missing expectations by -84.77%.
Earnings released on 12 Aug 2022
EPS came in at -$0.19 surpassing the estimated -$0.22 by +13.64%, while revenue for the quarter reached $1.30M , beating expectations by +452.68%.
Earnings released on 13 May 2022
EPS came in at -$0.22 falling short of the estimated -$0.21 by -4.76%, while revenue for the quarter reached $233.00K , missing expectations by -1.02%.
Earnings released on 29 Mar 2022
EPS came in at -$0.22 falling short of the estimated -$0.19 by -15.79%, while revenue for the quarter reached $177.00K , missing expectations by -27.95%.
Earnings released on 12 Nov 2021
EPS came in at -$0.72 falling short of the estimated -$0.21 by -242.86%, while revenue for the quarter reached $241.00K .
Earnings released on 16 Aug 2021
EPS came in at -$0.17 surpassing the estimated -$0.56 by +70.18%, while revenue for the quarter reached $690.00K .
Earnings released on 17 May 2021
EPS came in at -$0.20 surpassing the estimated -$0.90 by +77.78%, while revenue for the quarter reached $155.00K .
Earnings released on 16 Feb 2021
EPS came in at -$5.61 , while revenue for the quarter reached $124.00K .
Earnings released on 12 Nov 2020
EPS came in at -$1.43 , while revenue for the quarter reached $914.00K .
HUMA Stock Performance
Access detailed HUMA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.